Article complete

Amgen is Launching Biotechnology and AI Hub in Hyderabad

Som Chattopadhyay has been appointed as the national executive for India, leading the expanded operations.

Amgen is Launching Biotechnology and AI Hub in Hyderabad

Key takeaways

  • Amgen announces establishment of a biotechnology and AI hub in Hyderabad by Q4 2024.
  • New facility will support drug pipeline and enhance digital capabilities across global operations.
  • Amgen India will create up to 3,000 jobs in AI, data science, and life sciences.
  • Som Chattopadhyay appointed as national executive to lead operations in India.
  • Telangana Chief Minister welcomes Amgen's investment as a boost to local biotechnology sector.

Takeaways drafted with AI from the article text.

Amgen, a company focusing on biotechnology, discovering, developing, manufacturing, and delivering innovative medicines, has announced plans to establish a new technology and innovation site in Hyderabad, India, to accelerate digital capabilities across its global operations. 

The site, named Amgen India, will support the advancement of Amgen's drug pipeline and is expected to be operational by Q4 2024.

Located in HITEC City, Hyderabad, the facility will span six floors of the RMZ Spire Tower 110, accommodating up to 3,000 employees. Hyderabad was selected for its strong talent pool in medicine, life sciences, data sciences, and AI.

Amgen India will focus on developing new technology solutions and digital capabilities to enhance operational efficiencies across the enterprise. The site will create roles in AI, data science, life science, and other global capabilities as the operation expands.

Telangana Chief Minister Sri Anumula Revanth Reddy welcomed the development, stating, “We are proud to welcome a global trailblazer of the biotechnology industry. Amgen’s unwavering mission to serve patients will be incredibly inspiring for the world-class technology talent seeking to make a meaningful impact on people around the world.”

Amgen, with nearly 27,000 employees, has a global presence in approximately 100 countries and regions, including India.

With more than 40 years in the industry, Amgen continues to advance a broad pipeline of treatments for cancer, heart disease, osteoporosis, inflammatory diseases, and rare conditions.

Published

Corrections: AIM corrects errors of fact and notes the change on the story. Spotted one? Tell the editors. Read our editorial standards.

More in this story

Hyderabad · 5 stories
  1. You are here: Amgen is Launching Biotechnology and AI Hub in Hyderabad
  2. Hyderabad Emerges as Global Beauty Tech Hub with L’Oréal’s Largest GCC Investment
  3. Telangana Unveils Life Sciences Policy 2026–30 at Davos, Targets $25 Bn Investments
  4. Tredence Opens New AI Delivery Centre in Hyderabad, Plans 2,200 Workforce by 2027
  5. Synchrony Opens its Largest Global Experience Center in Hyderabad
About the author

Journalist

Mohit writes about AI in simple, explainable, and often funny words. He's especially passionate about chatting with those building AI for Bharat, with the occasional detour into AGI.

All stories
Belamy · Daily

The day’s AI news, before your first meeting.